Determination of factors affecting gene regulation and/or gene replication
AssigneeBio-Orbit Oy
InventorsMatti Karp, Matti Korpela
Life of this patent
Estimating the term…
Loading patent…
AssigneeBio-Orbit Oy
InventorsMatti Karp, Matti Korpela
Estimating the term…
The invention relates to a method for determining a factor affecting a cell, which affects directly or indirectly the DNA, RNA and/or proteins of the cell or their synthesis machinery, in which recombinant DNA plasmid is transferred into the cell, and the initial point or points of the reproducing machinery responsible for its replication are subject to an adjustable promoter, which is controllable either by positive or negative feedback; the cell containing the recombinant DNA plasmid is brought into contact with the affecting factor; the affecting factor is allowed to affect the cell containing the recombinant DNA plasmid for a suitable time, after which the promoter adjusting the starting point of the reproducing machinery responsible for the replication of the recombinant DNA plasmid starts growing in the cell, unless the affecting factor has not inhibited the replication of the plasmid; the shift of the copy number of the recombinant DNA plasmid in the cell is determined directly or indirectly.
A method for determining the presence or amount of at least one inhibitory factor in the sample to be tested, wherein the inhibitory factor inhibits one or more of DNA synthesis, transcription of DNA, translation of RNA, cell wall synthesis, cell membrane function or metabolic functions which participate in or influence these processes, said method comprising:
A method for determining the presence or amount of at least one inhibitory factor in the sample to be tested, wherein the inhibitory factor inhibits one of more of DNA synthesis, transcription of DNA, translation of RNA, cell wall synthesis, cell membrane function or metabolic functions which participate in or influence these processes, said method comprising:
A method for determining the presence of at least one inhibitory factor selected from the group consisting of ampicillin, chloramphenicol, oxytetracycline, streptomycin, erythromycin, ofloxacin, ciprofloxacin, actinomycin and trimethoprim in a sample of a biological fluid selected from the group consisting of blood, plasma, serum, urine, semen and milk, said method comprising:
Dependencies are inferred from the claim text.